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Abstract
The generation of induced pluripotent stem cells (iPSCs) often results in aberrant epigenetic
silencing of the imprinted Dlk1-Dio3 gene cluster, which compromises the cells’ ability to
generate entirely iPSC-derived adult mice (“all-iPSC mice”). Here, we show that reprogramming
in the presence of ascorbic acid attenuates hypermethylation of Dlk1-Dio3 by enabling a
chromatin configuration that interferes with binding of the de novo DNA methyltransferase
Dnmt3a. This allowed us to generate all-iPSC mice from mature B cells, which have thus far
failed to support the development of exclusively iPSC-derived postnatal animals. Our data
demonstrate that transcription factor-mediated reprogramming can endow a defined, terminally
#Corresponding author (khochedlinger@helix.mgh.harvard.edu).
4Present address: The Helen L. and Martin S. Kimmel Center for Biology and Medicine at the Skirball Institute of Biomolecular
Medicine, New York University, 540 First Avenue, New York, NY 10016, USA
*These authors contributed equally
Data access
mRNA microarray data have been deposited in NCBI’s Gene Expression Omnibus and are accessible under accesion number
GSE34761. ChIP-seq data have been submitted to the Sequence Read Archive under accession number SRA048788.
Author Contributions
M.S., E.A. and K.H. conceived the experiments, analyzed the data and wrote the manuscript. M.S. and E.A. performed the majority of
experiments. F.F. and P.J.P. analyzed genome-wide histone modification data; T.S. analyzed gene expression data; J.C. and S.Y.K.
performed tetraploid embryo complementation experiments; R.M.W. generated Southern blot data; T.C, S.O. and T.B. provided
Dnmt3a and Dnmt3l null fibroblasts.
NIH Public Access
Author Manuscript
Nat Genet. Author manuscript; available in PMC 2013 January 07.
Published in final edited form as:
Nat Genet. ; 44(4): 398–S2. doi:10.1038/ng.1110.
$
w
a
t
e
r
m
a
r
k
-
t
e
x
t
$
w
a
t
e
r
m
a
r
k
-
t
e
x
t
$
w
a
t
e
r
m
a
r
k
-
t
e
x
tdifferentiated cell type with a developmental potential equivalent to that of embryonic stem cells.
More generally, these findings indicate that culture conditions during cellular reprogramming can
strongly influence the epigenetic and biological properties of resultant iPSCs.
Introduction
Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by the
enforced expression of defined transcription factor combinations, such as Oct4, Klf4, Sox2
and c-Myc (OKSM)1. Since iPSCs can differentiate into virtually any somatic cell type, they
provide an invaluable tool for the study of development and disease2. Recent reports have
suggested that, compared to blastocyst-derived embryonic stem cells (ESCs), iPSCs harbor
genetic and epigenetic abnormalities, including the dysregulation of imprinted genes, gene
copy number variations, accumulation of point mutations and aberrant methylation
patterns3. To harness the full potential of iPSCs technology, it is important to understand the
mechanisms underlying these aberrations and to find ways to prevent them.
We have previously used microarrays to show that RNA expression patterns of ESCs and
iPSCs are essentially indistinguishable with the exception of a few maternally-expressed,
non-coding transcripts (e.g., Gtl2 and Rian) and miRNAs originating from the imprinted
Dlk1-Dio3 gene cluster4, which is silenced in the majority of iPSC lines5. We termed iPSC
lines exhibiting aberrant silencing of Dlk1-Dio3 transcripts Gtl2off iPSCs and cell lines with
an ESC-like expression Gtl2on iPSCs. In accordance with developmental defects seen in
mutants encompassing the Dlk1-Dio3 cluster4,6, Gtl2off iPSCs failed to yield all-iPSC mice
upon tetraploid (4n) blastocyst injections5,7, the most stringent assay for developmental
potential. Based on these results, we concluded that the stable repression of maternal Dlk1-
Dio3 transcripts acts as a roadblock for the establishment of full pluripotency in iPSCs.
In this manuscript, we offer novel insights into the molecular mechanisms of aberrant Dlk1-
Dio3 silencing in iPSCs and provide an efficient way to prevent it by supplementing
reprogramming cultures with ascorbic acid. We further demonstrate the utility of this
approach by generating entirely iPSC-derived mice from terminally differentiated B
lymphocytes.
Dlk1-Dio3 hypermethylation occurs late and requires Dnmt3a
We first determined the kinetics of Gtl2 expression by analyzing defined, purified
reprogramming intermediates8 obtained from murine embryonic fibroblasts (MEFs) carrying
a transgenic reprogramming system9 (Figure 1a). Analysis of these intermediates showed
rapid downregulation of Gtl2 RNA upon OKSM expression, concurrent with the extinction
of the fibroblast marker gene Fbn2, but prior to activation of the pluripotency genes Nanog
and endogenous Oct4 (also called Pou5f1) (Figure 1b). In contrast to the early
downregulation of Gtl2 RNA, abnormal hypermethylation of CpG-dinucleotides within the
IG-DMR (intergenic differentially methylated region), which correlates with stable gene
silencing of maternally-encoded transcripts4, was only evident at later reprogramming
stages. Note that wild type somatic cells and ESCs show methylation levels of ~50% at the
IG-DMR, reflecting the silenced and completely methylated paternal copy of Dlk1-Dio3.
Interestingly, the timing of IG-DMR hypermethylation coincided with the demethylation of
the endogenous Oct4 promoter (Figure 1c), which indicates successful epigenetic
reprogramming to pluripotency2. Therefore, repression of maternal Dlk1-Dio3 transcripts
appears to occur in two distinct waves, with transcriptional downregulation preceding the
acquisition of aberrant DNA methylation and thus stable gene silencing.
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tDuring male germ cell development, the IG-DMR is methylated by the de novo DNA
methyltransferase Dnmt3a to establish an imprint that is maintained throughout adulthood10.
Additionally, the non-enzymatic protein Dnmt3l has been implicated in Dlk1-Dio3
imprinting, although its involvement in this process remains controversial10–12. To
genetically test whether Dnmt3a and Dnmt3l are responsible for the hypermethylation
observed in iPSCs, we reprogrammed MEFs lacking either Dnmt3a10 or Dnmt3l12 (Figure
1d). The majority of resultant Dnmt3a-deficient iPSC clones exhibited normal (40–50%)
methylation levels at both the IG-DMR and a second DMR proximal to the Gtl2 promoter
termed Gtl2 DMR4, indicating that Dnmt3a catalyzes the hypermethylation seen in Gtl2off
iPSCs (Figure 1e). As expected, Dnmt3a-deficient iPSC clones expressed higher Gtl2
transcript levels compared with control cells (Figure 1f and Supplementary Figure 1a). In
contrast, Dnmt3l-deficient iPSCs exhibited, on average, only a small decrease of
methylation levels and a less pronounced increase of Gtl2 expression levels (Figure 1e, f and
Supplementary Figure 1b). Together, these results provide genetic evidence that Dnmt3a is
essential for, while Dnmt3l promotes, Dlk1-Dio3 hypermethylation during the generation of
Gtl2off iPSCs. The observation that rare Dnmt3a-deficient iPSCs (2/15) exhibited slightly
elevated DNA methylation levels at the IG-DMR (Supplementary Figure 1a) and expressed
reduced Gtl2 RNA levels might be explained by delayed Cre-mediated excision of Dnmt3a
during reprogramming or by alternative mechanism of gene silencing.
Serum replacement and ascorbic acid prevent Gtl2 silencing
We next sought to identify an efficient and safe approach to prevent Dlk1-Dio3 silencing,
that does not depend on genetic interference with Dnmt3a, by testing alternative iPSC
derivation protocols. Specifically, we evaluated the effects of omitting feeder cells or using
serum replacement (SR)13 instead of FBS during reprogramming (Figure 2a). As shown in
Figure 2b, the majority of iPSCs derived in FBS-containing media in the presence or
absence of feeders expressed only residual levels of Gtl2 (11/12 and 6/9 of clones,
respectively), indicating that feeders do not significantly influence the outcome of Dlk1-
Dio3 silencing. Surprisingly, however, 8/9 iPSC clones produced in SR and 6/6 iPSC clones
derived in a mix of FBS and SR expressed normal levels of Gtl2, indicating that SR contains
a dominant activity that prevents silencing of Dlk1-Dio3 normally incurred by FBS (Figures
2b, c).
SR contains ascorbic acid (also known as vitamin C), which has been shown to influence
DNA methylation patterns in human ESCs14 and may thus be responsible for inhibiting
aberrant Dlk1-Dio3 silencing. Indeed, addition of ascorbic acid to FBS-containing media
during MEF reprogramming abrogated hypermethylation of the IG-DMR and Gtl2 DMR
and maintained normal expression levels of Gtl2 in a concentration-dependent manner
(Figures 2d, e and Supplementary Figure 2). Consistent with a previous report15, exposure
of cells expressing OKSM to ascorbic acid also substantially increased reprogramming
efficiencies (from 0.5–1% to about 4%) and speed (five days of OKSM expression were
sufficient to generate dox-independent colonies) (Supplementary Figure 3a, b).
Ascorbic acid and alternative reprogramming strategies
Recent reports have documented roles for exogenous c-Myc expression16,17 and
reprogramming factor stoichiometry18 in the outcome of Dlk1-Dio3 imprinting in iPSCs,
suggesting that ascorbic acid may prevent Gtl2 silencing by modulating these parameters.
However, all MEF-iPSC lines (9/9) generated by exogenous expression of only three factors
(OKS) in the absence of ascorbic acid exhibited hypermethylation of the IG-DMR and Gtl2
DMR (Supplementary Figure 4). We were further unable to find measurable differences in
total or relative protein levels of OKSM between ascorbic acid-treated and untreated
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treprogrammable MEFs (Supplementary Figure 3c) and hence conclude that ascorbic acid
prevents Dlk1-Dio3 silencing independently of factor levels and stoichiometry.
We confirmed the recent observation that reprogramming of MEFs using an alternative
polycistronic cassette (OSKM), that produces the four reprogramming factors at different
stoichiometries compared with our system (OKSM), gives rise to fewer Gtl2off iPSCs18
(Supplementary Figure 5b). By directly comparing these two transgenic systems, we made
additional observations that are worth mentioning here. First, the efficiency of MEF-iPSC
formation with the alternative OSKM system was significantly lower (at least one order of
magnitude) (Supplementary Figure 5a), raising the possibility that different subsets of cells
present in heterogenous fibroblast cultures might have been reprogrammed with the two
systems. Second, we noticed that the majority of bone marrow (BM)-derived iPSC clones
derived with either transgenic system exhibited hypermethylation of the IG-DMR and Gtl2
DMR (6/8 with OKSM and 15/18 with OSKM), suggesting that factor stoichiometry was
either suboptimal in those BM cells that gave rise to iPSCs, or pointing to a cell type-
specific effect on Dlk1-Dio3 silencing that is independent of factor stoichiometry
(Supplementary Figure 5c, d). Treatment of OSKM BM cells undergoing reprogramming
with ascorbic acid also prevented aberrant silencing in the majority of resultant iPSC clones
(7/8). Lastly, several MEF-iPSC clones derived with the OSKM transgene (7/18) exhibited
hypomethylation (<30% of CpGs methylated) of both the IG-DMR and Gtl2 DMR,
irrespective of the presence of ascorbic acid (Supplementary Figure 5b). The biological
relevance of this observation remains unclear.
Importantly, seven of seven MEF-iPSC clones generated with four individual lentiviral
vectors8 showed IG-DMR hypermethylation in the absence of ascorbic acid, which could be
prevented by addition of the compound (Supplementary Figure 6). This indicates that Dlk1-
Dio3 silencing is not a peculiarity of the polycistronic construct used in our study but rather
a general phenomenon during iPSC derivation in conventional culture conditions.
Specificity of ascorbic acid treatment
MEF-iPSCs generated with or without ascorbic acid showed complete DNA demethylation
and acquisition of the activating H3K4me3 histone mark at the Oct4 promoter
(Supplementary Figure 7), indicating that epigenetic remodeling of this key pluripotency
gene is not affected by ascorbic acid treatment. We also failed to detect differences in the
methylation levels of other imprinted genes including the paternally imprinted H19 and
Rasgrf1 genes and the maternally imprinted Mest and Peg3 genes (Supplementary Figure 8a,
b), demonstrating that ascorbic acid does not globally affect imprinted gene methylation.
Following retinoic acid exposure, ascorbic acid-treated iPSC clones upregulated Dlk1 to
similar levels as those seen in ESCs (Supplementary Figure 8c), documenting appropriate
transcriptional control of the Dlk1-Dio3 locus upon differentiation. Lastly, global gene
expression profiling showed that maternal transcripts of the Dlk1-Dio3 locus were the only
discernible difference between MEF-iPSCs derived in the presence and absence of ascorbic
acid (Figure 2f), respectively, suggesting that its supplementation during reprogramming
does not have lasting effects on the expression of other genes in the pluripotent state.
To test whether treatment with ascorbic acid de-represses the normally silenced paternally-
inherited allele of Gtl2 and causes a switch of imprinted alleles, we derived iPSCs from M.
musculus×M. castaneus hybrid fibroblasts that carry a single nucleotide polymorphism
(SNP) on the paternal allele of Gtl2 (Supplementary Figure 9a). All analyzed Gtl2on iPSCs
clones (9/9) expressed only the maternal Gtl2 allele (Supplementary Figure 9b,c), indicative
of imprint stability at the Dlk1-Dio3 locus.
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tAscorbic acid exposure of established Gtl2off iPSCs for 15 passages was insufficient to
reverse silencing, as documented by sustained hypermethylation of both the IG-DMR and
Gtl2 DMR (Supplementary Figure 10). These observations reveal that ascorbic acid
treatment prevents but cannot reverse aberrant DNA methylation of the Dlk1-Dio3 locus.
Ascorbic acid preserves active chromatin marks at Dlk1-Dio3
To gain insights into the mechanism by which ascorbic acid might counteract epigenetic
silencing of Dlk1-Dio3, we isolated SSEA1+ intermediates from MEFs undergoing
reprogramming either in the presence or absence of the compound and analyzed histone
modifications at the IG-DMR that have previously been correlated with DNA methylation.
As shown in Figure 3, MEFs undergoing reprogramming in FBS alone rapidly lost the
activating histone marks acetylated histone H3 (acH3) and H3 lysine 4 dimethylation
(H3K4me2) and failed to gain H3 lysine 4 trimethylation (H3K4me3) (Supplementary
Figure 11a), a modification seen in ESCs and Gtl2on iPSCs but not in MEFs and Gtl2off
iPSCs. In contrast, ascorbic acid-treated intermediates maintained H3K4me2 and acH3 and
gained H3K4me3 levels at the IG-DMR during reprogramming, ultimately reaching levels
comparable to those seen in ESCs (Figure 3b,c and Supplementary Figure 11a). We did not
detect significant differences in the repressive H3 lysine 27 trimethylation (H3K27me3)
mark in intermediates or established pluripotent cell lines (Supplementary Figure 11b).
Thus, ascorbic acid treatment preserves an active histone configuration at Dlk1-Dio3, which
is frequently lost in regular (FBS-containing) reprogramming conditions.
To correlate the observed changes in histone modifications at Dlk1-Dio3 with DNA
methylation patterns, we analyzed methylation levels at the IG-DMR in the same
reprogramming intermediates. This showed that untreated fibroblasts undergoing
reprogramming become progressively hypermethylated at later reprogramming stages, while
ascorbic acid-treated intermediates maintain normal DNA methylation levels throughout the
process (Figure 3d, see also Figure 1c). Importantly, aberrant DNA hypermethylation
coincided with increased binding of Dnmt3a to the IG-DMR in late reprogramming
intermediates in the absence of ascorbic acid (Figure 3e), which is consistent with the
previous observation that Dnmt3a can only recognize unmodified histone H3K4 tails19,20.
We failed to detect increased expression of DNA methyltransferase genes in untreated
intermediates, thus ruling out that hypermethylation is the consequence of transcriptional
upregulation of these enzymes (Supplemental Figure 12).
Ascorbic acid has anti-oxidative activity, which may be critical for its inhibitory effect on
Dlk1-Dio3 hypermethylation. However, the majority of iPSCs clones derived under reduced
oxygen conditions or in the presence of the alternative antioxidant resveratrol still showed
IG-DMR hypermethylation (Supplemental Figure 13), thus arguing against the importance
of ascorbic acid’s antioxidative properties in preventing Dlk1-Dio3 silencing. It is possible,
though, that other antioxidative agents may mirror the effects ascorbic acid treatment on the
Dlk1-Dio3 locus. Together, these observations suggest that the rapid loss of activating
histone marks in the absence of ascorbic acid facilitates the recruitment of Dnmt3a to the
IG-DMR, which catalyzes DNA hypermethylation and leads to stable epigenetic silencing of
maternal Dlk1-Dio3 transcripts (see model in Figure 3f).
Gtl2on iPSCs derived from mature B cells
To date, Gtl2on iPSCs have only been obtained from heterogeneous fibroblast cultures while
more defined, non-fibroblast populations such as hematopoietic cells and keratinocytes
consistently yielded Gtl2off iPSCs with impaired developmental potency as judged by 4n
embryo complementation5. To evaluate whether ascorbic acid treatment facilitates the
generation of Gtl2on iPSCs from a defined, terminally differentiated cell type, we isolated
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tCD19+ B cells from the spleens of adult reprogrammable mice9 and cultured them in
doxycycline-containing media in the presence or absence of ascorbic acid for 14 days until
iPSC colonies emerged (Figure 4a and Supplementary Figure 14). The efficiency of iPSC
formation from mature B cells (B-iPSC) ranged between 0.02% and 0.06% in the presence
of ascorbic acid and between 0.01% and 0.05% in the absence of ascorbic acid (data not
shown), representing a less dramatic increase in reprogramming efficiency following
ascorbic acid treatment than that seen with fibroblasts (Supplementary Figure 3a). While all
B-iPSCs generated without ascorbic acid (36/36) exhibited aberrant hypermethylation of the
IG-DMR and Gtl2 DMR and/or diminished Gtl2 transcript levels, 4/17 (24%) iPSC clones
established in a mix of FBS and SR and 5/11 (45%) clones derived in the presence of
ascorbic acid showed normal DNA methylation patterns and expressed Gtl2 at ESC-like
levels (Figure 4b and Supplementary Figure 15). The lower frequency of obtaining Gtl2on
B-iPSCs than MEF-iPSCs might be due to the higher baseline methylation levels of the IG-
DMR in B lymphocytes and the extremely low expression levels of Gtl2 in these cells
(Supplementary Figure 16). Gtl2on B-iPSCs exhibited typical ESC-like morphology,
homogenously expressed endogenous pluripotency markers (Figure 4c), showed DNA
demethylation and enrichment for H3K4me3 at the Oct4 promoter and had a predominantly
normal karyotype (Supplementary Figure 17). Collectively, these data show that ascorbic
acid treatment efficiently preserves normal genomic imprinting at Dlk1-Dio3 during the
reprogramming of a defined, terminally differentiated non-fibroblast cell type.
Given that H3K4me3 deposition at the Dlk1-Dio3 locus in reprogramming intermediates
was strongly affected by ascorbic acid treatment (see Supplementary Figure 11a), we
wondered whether H3K4me3 patterns might be altered on a genome-wide scale in iPSCs by
this compound. To this end, we performed ChIP-Seq analysis for the H3K4me3
modification in two B-iPSC clones derived in the presence of ascorbic acid (one Gtl2on and
one Gtl2off) and one fully pluripotent ESC line5, that had never been exposed to ascorbic
acid. Bioinformatic analysis of sequenced reads from these clones confirmed the absence of
the activating H3K4me3 modification at the Gtl2 locus in the Gtl2off clone while
pluripotency loci such as Nanog and Oct4 were similarly enriched for H3K4me3 in all
pluripotent cell lines (Figure 4d). Both B-iPSC clones exhibited a very high degree of
overlap in global H3K4me3 patterns (>95%) compared with the control ESC line (Figure 4e,
f). Our ChIP-seq results also showed a large overlap with a previously published dataset on
genome-wide H3K4me3 patterns in ESCs21 (Figure 4d and Supplemental Figure 18), further
suggesting that ascorbic acid exposure does not cause major global epigenetic aberrations of
at least this key epigenetic mark. It remains to be tested whether the few detected differences
among the various samples (Figure 4f and Supplementary Table 1) are truly the result of
ascorbic acid exposure or rather caused by line-to-line variation as has been seen before
among pluripotent cell lines22.
All-iPSC mice generated from mature B cells
Lastly, we tested the developmental potential of B-iPSCs derived in the presence of ascorbic
acid by 4n embryo complementation23,24 (Figure 5a). It should be noted that adult all-iPSC
mice have thus far only been produced from fibroblast populations while attempts to
produce 4n complementation-competent mice from defined adult cell types such as neural
progenitor cells25 or lymphocytes26 have been unsuccessful, likely due to embryonic growth
arrest at midgestation25. Remarkably, all Gtl2on B-iPSC clones tested with this rigorous
assay (4/4) gave rise to neonatal “all-iPSC” mice whereas two tested Gtl2off clones only
yielded late-stage resorptions (Table 1). Given that Gtl2 null animals die pre- or perinatally6,
our results do not exclude the possibility that rare Gtl2off all-iPSC mice can develop as far as
full-term before they succumb, consistent with a recent report18. We confirmed that viable
animals were entirely derived from B-iPSCs by PCR for strain-specific polymorphisms
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immunoglobulin heavy chain locus (Figure 5c). All-iPSC neonates generated from three of
the four Gtl2on clones survived at least for several days, and animals derived from two of the
clones reached adulthood and exhibited uniform agouti coat color (Table 1 and Figure 5d).
Peripheral B cells isolated from an adult all-B-iPSC mouse expressed immunoglobulins
composed of essentially only kappa light chain on their surface (Figure 5e) while B cells
from control mice produced both kappa and lambda immunoglobulins, further supporting
the monoclonal origin of B cells in mice derived from B-iPSCs. We also obtained agouti
offspring from all-B-iPSC mice, documenting successful germline transmission (Figure 5f).
These data demonstrate that Gtl2on iPSCs produced from terminally differentiated B cells
can support the development of entirely iPSC-derived adult monocolonal mice.
Discussion
Here, we have shown that ascorbic acid treatment efficiently preserves a normal imprinting
status at the Dlk1-Dio3 gene cluster during the derivation of mouse iPSCs from different
adult cell types and using various means of reprogramming factor expression. Our data
suggest that ascorbic acid inhibits Dlk1-Dio3 silencing by interfering with OKSM-induced
loss of H3K4 methylation at the maternal IG-DMR by an as yet to be identified mechanism.
Sustained H3K4 methylation then prevents the recruitment of Dnmt3a, which is essential for
Dlk1-Dio3 DNA hypermethylation. Surprisingly, iPSC lines derived in the presence of
ascorbic acid did not exhibit detectable expression changes of transcripts outside the Dlk1-
Dio3 cluster, altered DNA methylation patterns at a number of additional imprinted genes or
major differences in genome-wide H3K4me3 occupancy, suggesting a remarkable
specificity. However, it is possible that ascorbic acid influences other chromatin marks in
iPSCs that do not adversely affect their developmental potential as measured by the ability
of B-iPSCs to generate adult all-iPSC mice. Given its strong effect on reprogramming speed
and efficiency, it is conceivable that ascorbic acid introduces widespread but transient
alterations into chromatin that are resolved upon entry into a pluripotent state and hence
undetectable in established iPSCs. It is noteworthy that a recent report connected ascorbic
acid with the H3K36 demethylase Kdm2b during iPSC formation27. It should thus be
informative to test whether Kdm2b may also be involved in preventing Dlk1-Dio3 silencing.
Furthermore, the maternally expressed microRNA mir-369 encoded within the Dlk1-Dio3
cluster has recently been suggested to reprogram fibroblasts into iPSCs in combination with
other select microRNAs28, raising the possibility that ascorbic acid may in part increase
reprogramming efficiency by maintaining normal Dlk1-Dio3 imprinting.
Addition of ascorbic acid to cells undergoing reprogramming allowed us to derive Gtl2on
iPSCs from mature B cells, which supported the development of adult all-iPSC mice. To our
knowledge, this is the first demonstration that full developmental potential can be reinstated
in iPSCs produced from a terminally differentiated adult cell of defined origin. While we
were unable to generate Gtl2on B-iPSC clones in the absence of ascorbic acid using our
reprogrammable system, we cannot rule out that alternative reprogramming cocktails or
constructs may facilitate their derivation in standard conditions. Also, our observation that
adult all-iPSC animals could not be obtained from every Gtl2on B-iPSC clone tested
indicates that normal expression of Dlk1-Dio3 alone is a valuable indicator but not an
absolute predictor for postnatal survival of all-iPSC mice. This finding further implies that
other cell line-specific epigenetic and/or genetic abnormalities may be present in iPSCs,
which should be identifyable with deep sequencing approaches.
The ability to generate all-iPSC animals from single B lymphocytes might provide an
efficient way to produce monoclonal mice with desired antibody specificities for
immunological studies. Our observations should also help to streamline the production of
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it will be important to evaluate if the expression status of Gtl2 correlates with other
transcriptional, epigenetic or genetic features of iPSCs, which have escaped detection with
the assays employed thus far. More generally, our results make the unexpected observation
that alterations of environmental conditions during cellular reprogramming can have
profound effects on the epigenetic and biological properties of derivative pluripotent cell
lines. Lastly, these data may have ramifications for ongoing comparative studies between
ESCs and iPSCs as well as disease modeling approaches.
Experimental procedures
Mice
Derivation, handling and genotyping of Col-OKSM reprogrammable mice was done as
described previously9.
Cell culture
ESCs and established iPSCs were cultured on irradiated feeder cells (Global Stem) in KO-
DMEM (Invitrogen) supplemented with L-Glutamine, penicillin-streptomycin, non-essential
amino acids, β-mercaptoethanol, 1000 U/ml LIF (“ESC media”) and 15% fetal bovine
serum (FBS) (HyClone). MEF cultures were established by trypsin-digestion of
midgestation (E13.5–15.5) embryos followed by culture in DMEM supplemented with 10%
FBS, L-Glutamine, penicillin-streptomycin, non-essential amino acids and β-
mercaptoethanol. B cells were defined as CD19+c-kit−Mac-1− cells and isolated from adult
spleen using monoclonal antibodies against CD19 (1D3), c-kit (2B8) and Mac-1 (CD11b,
M1/70) obtained from eBiosciences. c-kit and Mac-1 were used to ensure the exclusion of
progenitor cells and macrophages/monocytes, respectively.
Reprogramming
Reprogramming experiments were routinely conducted in gelatinized plates seeded with a
feeder layer of irradiated MEFs, using ESC media supplemented with 1 µg/ml doxycycline
(dox) and either 15% FBS or 20% KnockOut Serum Replacement (SR) (Invitrogen).
Wherever indicated, ascorbic acid (Sigma A4544) was added to the reprogramming cultures
at the same time dox was added. For the reprogramming of B cells, interleukin-4 (80 ng/µl
final) and an antibody against CD40 (5 µg/ml final) were added to the cultures. After dox
withdrawal, cultures were grown in ESC media with 15% FBS without ascorbic acid.
Colonies with ESC morphology were picked four to six days after dox withdrawal. For the
isolation of intermediates, Col-OKSM MEFs were seeded on feeders in ESC media
containing FBS and dox either in the presence or absence of ascorbic acid. Cells were
harvested on day 6 after dox induction (“early intermediates”), on day 12 after dox induction
(“late intermediates”) and after another 4–6 days of culture after dox withdrawal on day 12
(“dox-independent intermediates”). Cells were stained with biotinylated anti-SSEA1
(MC-480) and eFluor 450-conjugated anti-CD90.2 (Thy1.2, 53–2.1) antibodies, and the
SSEA1+ fraction was either isolated by flow-activated cell sorting (FACS) as described
before8 or by magnetic-activated cell sorting (MACS) after incubation with Streptavidin
microbeads (Miltenyi Biotec) using the positive selection program on an AutoMACS cell
separator according to the manufacturer’s instructions. The purity of all isolated cell
fractions was confirmed by flow cytometric analysis using an LSR2 machine (BD).
Established iPSCs were isolated by trypsinization followed by 45 minutes of pre-plating to
remove feeder cells. DNMT3afloxed/floxed and Dnmt3lnull MEFs were co-transduced with a
dox-inducible lentivirus expressing OKSM29, a constitutive lentivirus expressing rtTA8 and,
in case of Dnmt3a MEFs, a constitutive retrovirus driving expression of Cre recombinase30.
Complete excision of the conditional alleles was confirmed by PCR10. OKS iPSCs were
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Klf4 and Sox2 (E.A. and K.H., unpublished).
Viral vector production
Viral vectors were produced as previously described8. Briefly, 293T cells were co-
transfected with vector plasmid and packaging plasmids using Fugene (Roche) transfection
reagent. Viral supernatants were harvested between 48 and 72 hours after transfection and
concentrated by ultracentrifugation at 20,000 rpm for 1.5 hours at 4°C. Viral concentrates
were resuspended in PBS and stored at −80°C. Transduction of MEFs was carried out in
MEF media containing 5µg/ml polybrene.
Analysis of DNA methylation
MEFs and B cells were pelleted and then resuspended in lysis buffer, pH 8 (100 mM Tris-
HCl, 5 mM EDTA, 0.2% SDS, 200 mM NaCl) with proteinase K. ESCs and dox-
independent iPSC clones at passage 2 or higher were seeded on gelatinzed plates without
feeders, grown to confluency and then lysed. Genomic DNA was precipitated with 100%
isopropanol and reconstituted in TE buffer, pH 7.5 (10 mM Tris-HCl, 1 mM EDTA). DNA
was bisulfite-converted using the EpiTect Bisulfite Kit (Qiagen) and analyzed by EpigenDX
using the following assays: ADS1452 (IG-DMR), ADS1341 (Gtl2 promoter), ADS438
(ICR1-H19), ADS936 (Rasgrf1) and ASY585 (Oct4 proximal promoter). The precise
genomic position of all CpGs assayed is listed in Supplementary Table 2.
SSLP analysis
Genomic DNA was isolated from tail-tip biopsies or primary B cells and PCR reactions set
up using primers which detect described polymorphisms in the genome of inbred mouse
strains26 (listed in Supplementary Table 3) Reactions were performed with 100 ng of DNA
for 30 cycles of 30 seconds at 94° Celcius (C), 30 seconds at 60° C and 60 seconds at 72° C
and reaction products analyzed on a 3% agarose gel.
RNA isolation and quantification
MEFs and B cells were pelleted and used for RNA isolation with either the miRNeasy Mini
Kit or the RNeasy Mini Kit (Qiagen) without DNase digestion. ESCs and Dox-independent
iPSC clones at passage 2 or higher were seeded on gelatinzed plates without feeders and
then processed with the kits mentioned above. RNA was eluted from the columns using
RNase-free water or TE buffer and quantified using a Nanodrop. cDNA was produced with
the Transcriptor First Strand cDNA Synthesis Kit (Roche). Real-time quantitative PCR
reactions were set up in triplicate with the Brilliant II SYBR Green QPCR Master Mix
(Stratagene) using 5 µl of cDNA (1:100 dilution in water) and previously described
primers5,8. Reactions were run on a Mx3000P QPCR System (Stratagene) with 40 cycles of
30 seconds at 95° C, 30 seconds at 58° C and 30 seconds at 72° C. For detection of allele-
specific Gtl2 expression in M. musculus×M. castaneus F1 iPSCs, the qPCR amplicon was
digested with the endonuclease BstUI and run on a 3% agarose gel.
Western Blot analysis
Cells were harvested and lysed in 1x RIPA buffer. Protein concentration was measured
using BCA protein Assay reagent (ThermoScientific). 15 µg of cell extract was loaded and
western blot analysis was performed using standard protocols and probed with the following
antibodies: anti-Oct4 (sc-5279), anti-Sox2 (ab97959), anti-Klf4 (R&D, AF3158) and anti-
cMyc (sc-764).
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Total RNA samples (RIN>9) were subjected to transcriptional analyses using Affymetrix
Mouse 430_2 mRNA expression microarray similarly as previously described31.
Hierarchical clustering was performed using Cluster and Treeview software as well as the
GeneSifter server (Geospiza, Seattle).
Southern blot analysis
20 µg of genomic DNA was digested with EcoRI, separated on a 1% agarose gel, blotted
onto HybondXL membrane (Amersham Biosciences) and hybridized to a HindIII/EcoRI JH4
fragment probe32. Probe labeling with 32P-α-dCTP was done using the Prime-It® II
Random Labeling Kit (Stratagene) following the manufacturer’s instructions.
Chromatin immunoprecipitation
20 million iPSCs, ESCs or MEFs were fixed with 1% formaldeyde for 10 minutes at room
temperature (RT) and then lysed in 1ml lysis buffer (50mM Tris-HCl, pH 8.0, 10mM
EDTA, 1% SDS, protease inhibitors) for 20 minutes on ice. The lysate was split into three
tubes and sonicated using Bioruptor for five times at high intensity, 30 sec. “on” and 30 sec.
“off”. After 10 minutes of centrifugation, the supernatant was pre-cleared for 1 hour at 4°C
with agarose beads pre-blocked with BSA (1mg BSA for 10ml beads) in IP Buffer (50mM
Tris-HCl, pH8, 150mM NaCl, 2mM EDTA, 1% NP-40, 0.5% Sodium Deoxycholate, 0.1%
SDS, protease inhibitors). 100ul of pre-cleared chromatin per reaction diluted in 1ml IP
Buffer in the presence of 2ug antibody were used for each reaction according to the
manufacturer's protocol. The antibodies used were: anti-acetyl histone H3 (Millipore, 17–
615), anti-dimethyl K4 of H3 (07–030, Millipore), anti-trimethyl K4 of H3 (Millipore, 17–
614), anti-trimethyl K27 of H3 (Millipore, 07–449), anti-Dnmt3a (IMGENEX, IMG-268A)
and normal rabbit IgG (Millipore). The precipitate was purified using QIAquick PCR
purification Kit and was analyzed by RT-PCR using primers listed in Supplementary Table
3.
ChIP-Sequencing
ChIP libraries were prepared using the NEBNext ChIP-Seq Prep Reagent Set1 of NEB
(NEB #E6200) following the manufacturer’s instructions and the Illumina/Solexa Genome
Analyzer Primer/Adapter Sequences. The libraries were sequenced using an Illumina GAII
Sequencing System.
ChIP-seq data analysis
Illumina sequencing reads were pre-processed with cutadapt tool (http://code.google.com/p/
cutadapt/) to trim adapter sequences if present, then aligned to mm9 reference genome with
bowtie33, using default alignment parameters but reporting only uniquely aligned reads.
Genomic regions with significant enrichment in H3K4me3 ChIP samples over matched
input samples were detected using R and spp package procedure for the identification of
broad enrichment clusters34. RefSeq transcripts annotations were downloaded from UCSC
genome browser database and matched with gene annotations (refGene and refLink tables).
For each RefSeq, a window +/−2kb centered at the transcription start site (TSS) is
considered. This window is truncated downstream the TSS if the RefSeq transcript is less
than 2kb long, and is also truncated upstream of the TSS if another RefSeq transcript end on
the same genomic strand is located less than 2kb upstream. Each RefSeq TSS is associated
with H3K4me3 enrichment if any overlap exists between the enrichment regions and the
selected TSS window. Then these overlaps are summarized at the gene level and each gene
is considered as associated to H3K4me3 enrichment if any of its RefSeq transcripts is
associated to H3K4me3 enrichment. In Venn diagrams the list of H3K4me3-associated
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R package. Publicly available data21 were re-analyzed using the same procedure.
Blastocyst injections
2n and 4n blastocyst injections were performed as described before23. Briefly, female BDF1
mice were superovulated by intraperitoneal injection of PMS and hCG and mated to BDF1
stud males. Zygotes were isolated from females with a vaginal plug 24 hour after hCG
injection. Zygotes for 2n injections were in vitro cultured for 3 days in KSOM media,
blastocysts were identified, injected with ESCs or iPSCs and transferred into
pseudopregnant recipient females. For 4n injections, zygotes were cultured overnight until
they reached the 2-cell stage, at which point they were electro-fused. One hour later, 1-cell
embryos were carefully identified and separated from embryos that had failed to fuse,
cultured in KSOM for another 2 days and then injected.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. Gtl2 hypermethylation occurs late during reprogramming and requires Dnmt3a
(a) Strategy for isolation and study of reprogramming intermediates using the doxycycline-
inducible Collagen-OKSM system. (b) Q-PCR showing the kinetics of Gtl2 repression
during reprogramming in relation to the expression of the fibroblast gene Fibrillin-2 (Fbn2)
and the pluripotency genes Nanog and Oct4 (Pou5f1). iPSC values were obtained with two
Gtl2off clones. (c) DNA methylation analyses for the IG-DMR and Oct4 promoter in MEFs,
reprogramming intermediates and established Gtl2off or Gtl2on iPSC clones. Error bars
indicate standard deviations (n=28 for IG-DMR and n=5 for Oct4; number of CpGs
analyzed). (d) Strategy for the generation of Dnmt3a- and Dnmt3l-deficient (null) iPSCs.
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conditional null MEFs (floxed, fl/fl) were con-transduced with OKSM virus and a Cre-
expressing retrovirus. (e) DNA methylation analyses for the IG-DMR and Gtl2 DMR in
Dnmt3a null (n=15), Dnmt3a wild-type (wt) (n=8), Dnmt3l null (n=14) and Dnmt3l wt
(n=14) iPSC clones. (f) Gtl2 expression levels, as measured by RT-PCR in Dnmt3a null,
Dnmt3l null and corresponding wt iPSC clones (see also Suppl. Figure 1). Dashed lines
indicate mean values.
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tFigure 2. Ascorbic acid treatment prevents Gtl2 silencing
(a) Strategy for the derivation of iPSCs from reprogrammable MEFs in serum-containing
media with feeder cells (FBS), serum-containing media without feeder cells (no feeders) and
in media containing serum replacement without feeder cells (SR). From the time of
doxycycline withdrawal, serum-containing media was used for all cultures. (b) Gtl2
expression levels of iPSC clones generated as outlined in (a). (c) Q-PCR analysis of Gtl2
expression in six independent iPSC clones derived in media containing a 1:1 mix of FBS
and SR. (d) Gtl2 expression levels in iPSC clones derived in the presence (+AA) or absence
(−AA) of 50 ng/ml ascorbic acid. Upon dox withdrawal, AA was removed from all cultures.
Clones marked by asterisks were used for mRNA microarray analysis shown in (f). Error
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tbars in (b)–(d) indicate one standard deviation; n=3. (e) DNA methylation analyses for IG-
DMR in iPSC clones generated in medium containing different concentrations of ascorbic
acid. Error bars indicate one standard deviation; n=28 (number of CpGs at the IG-DMR). (f)
Scatter plot of microarray data comparing iPSC clones derived with ascorbic acid (+AA) or
without ascorbic acid (−AA) with differentially expressed genes highlighted in green (two-
fold, P<0.05, t-test with Benjamini-Hochberg correction).
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tFigure 3. Epigenetic changes induced by ascorbic acid during reprogramming
(a) Schematic representation of the Gtl2 locus. Arrowhead indicates region within IG-DMR
that was used for ChIP and DNA methylation analyses presented here. (b, c) Relative
enrichment of the activation marks, acetylated histone H3 (acH3) and dimethylated H3
lysine 4 (H3K4me2), respectively, at the IG-DMR in MEFs, ESCs and reprogramming
intermediates isolated from cultures in the absence (−AA) or presence (+AA) of ascorbic
acid. Open columns indicate the background levels of IgG antibody control. (d) DNA
methylation analyses for the IG-DMR in reprogramming intermediates. (e) ChIP-PCR
analysis detecting Dnmt3a binding at the IG-DMR in reprogramming intermediates. (f)
Proposed model of how ascorbic acid prevents aberrant methylation of the maternal Gtl2
allele during reprogramming. Factor X depicts as of yet unidentified activity(ies) that act
downstream of ascorbic acid to mediate observed epigenetic changes. Error bars in (a)–(e)
indicate one standard deviation; n=3.
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tFigure 4. Molecular characterization of B-iPSCs generated in the presence of ascorbic acid
(a) Strategy for the generation of B cell-iPSCs (B-iPSCs) from adult mice. (b) RT-PCR
analysis of Gtl2 expression (top graph) and DNA methylation analysis of IG-DMR (bottom
graph) in individual B-iPSC clones derived in the absence (−AA) or presence (+AA) of
ascorbic acid. The number “605” denotes the mouse used for B cell isolation. Error bars
indicate one standard deviation; n=3 PCR reactions (upper panel) and n=28 CpGs covered
by pyrosequencing analysis, respectively. (c) Representative image of a B-iPSC clone
showing typical morphology (top panel) and expression of Oct4-GFP (bottom panel). Scale
bars indicate 100 µm. (d) Reads density profile around the transcription start sites (TSSs) of
Nanog, Oct4 and Gtl2 for the H3K4me3 modification following genome-wide ChIP-Seq
analysis of the ascorbic acid-derived B-iPSC clones 605–35 (Gtl2off) and 605–57 (Gtl2on)
and one ESC line (ESC1). All samples were compared to a published data set19. Gaussian-
smoothed read density is normalized by library size. The vertical axis is adjusted to show the
whole peak if higher than 10. (e) Venn diagram representing overlap between H3K4me3-
enriched genes between ESC1 and the B-iPSC clones. The indicated percentages show
overlap with ESC1. Overlapping areas are not proportional to the actual number of genes. (f)
Region map of 4kb window around the TSSs of genes enriched for H3K4me3 in either
ESC1 or the individual B-iPSC clones. These are the same genes as reported in Figure 4e
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texcluding the 12,618 genes common to all three groups. The side bar marks genes, which
are enriched for H3K4me3 in ESC1 only (blue bar, 212 genes) or in both B-iPSC clones
only (red bar, 213 genes). The plot reports Gaussian-smoothed read density enrichment over
input samples in log2 scale. For each gene, the maximum enrichment across all of the
samples is used to compute a scaling factor so that maximum value is equal to 10.
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tFigure 5. Functional characterization of B-iPSC clones generated in the presence of ascorbic acid
(a) Strategy for the derivation of all-B-iPSC mice by tetraploid embryo complementation.
(b) Confirmation of origin of all-B-iPSC mice by PCR for strain-specific polymorphisms.
Two different Simple Sequence Polymorphism (SSLP) markers were tested using genomic
DNA isolated from tissues of all-BiPSC mice and the parental B cells. Genomic DNA from
BDF1 mice served as control for the presence of host blastocyst-derived cells. Triangles
indicate the position of strain-specific bands; open triangle = DBA/2 (host blastocyst-
specific) and black triangle = C57BL/6 (present in both host blastocysts, parental cells and
iPSCs). (c) Southern blot analyses of immunoglobulin heavy chain (IgH) locus
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trearrangement using genomic DNA isolated from different all-B-iPSC mice and the
corresponding four parental B-iPSC clones. DNA isolated from a MEF-iPSC clone was used
as a control to visualize unrearranged IgH germline configuration (single band). (d) Image
of two agouti all-B-iPSC mice at 5 weeks of age. (e) FACS analysis of B cells isolated from
a control (con) mouse and one all-B-iPSC mouse shows expression of only one type of
immunoglobulin (Ig) light chain (Ig-kappa or Ig-lambda), thus confirming monoclonality.
(f) Image of a three-month-old all-B-iPSC mouse (indicated by red asterisk) and its germline
offspring (5 agouti mice).
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